Read More Analyst Ratings News Price Target Upgrades Citigroup Upgrades Deere to Buy, Lowers Price Target to $340 By Benzinga Newsdesk Today, 9:57 AM Citigroup analyst Timothy Thein upgrades Deere (NYSE:DE) from Neutral to Buy and lowers the price target from $435 to $340. DE
Read More General News Politics President Biden To Virtually Meet With CEOs Of Medtronic, Lockheed Martin And Cummins On Semiconductor Chips Legislation By Benzinga Newsdesk Today, 9:57 AM -Reuters CMI
Read More Biotech FDA General News Moderna To Seek COVID-19 Vaccine Booster Clearance In Older Adults, High-Risk Individuals By Benzinga Newsdesk Today, 9:57 AM -Reuters MRNA
Read More Analyst Ratings News Price Target Raymond James Maintains Outperform on NGM Biopharmaceuticals, Raises Price Target to $27 By Benzinga Newsdesk Today, 9:57 AM Raymond James analyst Steven Seedhouse maintains NGM Biopharmaceuticals (NASDAQ:NGM) with a Outperform and raises the price target from $22 to $27. NGM